SuperSonic Imagine to Showcase Next-Generation Aixplorer® Ultimate’s Solutions for Liver Disease Management at The Liver M...
October 19 2017 - 12:03PM
Business Wire
At this DC meeting, attendees will view the
system’s 60-second non-invasive evaluation of liver stiffness with
real-time ShearWave™ Elastography
Regulatory News:
SuperSonic Imagine (Euronext: SSI, FR0010526814), a company
specializing in ultrasound medical imaging, announced today it will
be exhibiting at The Liver Meeting, held at Walter E. Washington
Convention Center, Washington, DC, October 20 – 24. The company
will introduce the Aixplorer Ultimate, which is a image guided
non-invasive liver disease assessment system during the American
Association for the Study of Liver Diseases (AASLD) meeting.
“The Aixplorer Ultimate’s image-guided ShearWave™ Elastography
(SWE™) technique enables physicians to measure tissue stiffness
non-invasively with color-coded images acquired in just 60
seconds,” explains Alex Exposito, Director of North America at
SuperSonic Imagine. “This evaluation of liver fibrosis severity*
provides a highly accurate alternative to biopsy, without the high
costs or risk of morbidity. This is particularly beneficial for
patients with hepatitis C and other diseases that require repeated
evaluations.”
The new Aixplorer Ultimate has expanded the technology evolution
through innovation thanks to exclusive UltraFast™ technology. The
Ultimate’s elegant new look and enhanced user interface make it
simple to use. The system’s computation power is more than 4.5
times faster and 20% more energy efficient than its predecessor.
Aixplorer Ultimate also includes a barcode scanner for inputting
patient information, reducing manual errors and saving time.
With its new Aixplorer Ultimate and its exclusive UltraFast
technology SuperSonic Imagine expands the platform, adding new
innovative features, making exams easier, without compromising
quality or performance. Non-invasive tools to evaluate liver
stiffness and non-alcoholic steatohepatitis (NASH) assessment are
at the point of care, making the procedure an extension of the
clinical examination
“We look forward to sharing the Aixplorer Ultimate’s
capabilities at The Liver Meeting. With SWE technology,
Gastroenterologists and Hepatologists can evaluate liver stiffness
for the assessment of liver fibrosis* and NASH severity without a
biopsy” said SuperSonic Imagine CEO MicheÌle Lesieur.
More than 120 international publications agree in demonstrating
the reliability and effectiveness of SuperSonic Imagine’s ShearWave
Elastography in the liver field.
Attendees can learn more about the Aixplorer Ultimate by
visiting SSI at booth #306 throughout The Liver Meeting.
*Pending FDA 510k
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France),
SuperSonic Imagine is a company specializing in medical imaging.
The company designs, develops and markets a revolutionary
ultrasound system, Aixplorer®, with an UltraFast™ platform that can
acquire images 200 times faster than conventional ultrasound
systems. In addition to providing exceptional image quality, this
unique technology is the foundation of several innovations which
have changed the paradigm of ultrasound imaging: ShearWave™
Elastography (SWE™), UltraFast™ Doppler and more recently Angio
PL.U.S – Planewave UltraSensitive™ Imaging. ShearWave Elastography
allows physicians to visualize and analyze the stiffness of tissue
in a real-time, reliable, reproducible and non-invasive manner.
This criteria has become an important parameter in diagnosing
potentially malignant tissue or other diseased tissue. As of today,
over 300 peer-reviewed publications have demonstrated the value of
SWE for the clinical management of patients with a wide range of
diseases. UltraFast Doppler combines Color Flow Imaging and Pulsed
Wave Doppler into one simple exam, providing physicians with exam
results simultaneously and helping to increase patient throughput.
The latest innovation, Angio PL.U.S, provides a new level of
microvascular imaging through significantly improved color
sensitivity and spatial resolution while maintaining exceptional 2D
imaging. SuperSonic Imagine has been granted regulatory clearances
for the commercialization of Aixplorer in key global markets.
SuperSonic Imagine is a listed company since April 2014 on the
Euronext, symbol SSI. For more information about SuperSonic
Imagine, please go to www.supersonicimagine.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171019006106/en/
SuperSonic ImagineMarketing & CommunicationEmmanuelle
Vellaemmanuelle.vella@supersonicimagine.com+33 4 86 79 03
27orNewCapInvestor Relations – EUPierre Laurent / Florent
Alba supersonicimagine@newcap.fr+33144719855orPascale
CommunicationMedia Relations - USAmy
Phillipsamy@pascalecommunications.com+1 412 327 9499
Stage Stores (NYSE:SSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stage Stores (NYSE:SSI)
Historical Stock Chart
From Sep 2023 to Sep 2024